Abstract
Hypoxia and ischemia play a major role in the pathogenesis of cerebrovascular diseases such as stroke. However, the protective strategies against hypoxic and ischemic insults are very limited in clinical settings. This has reinforced the need to improve our understanding of the hypoxic and ischemic cascades and explore novel solutions of hypoxic/ ischemic injury. Recent research has identified the crucial role of microRNAs in regulation of gene expression under hypoxic/ischemic conditions. These 19-24 ribonucleotide non-coding RNA molecules function as inhibitory modulators of gene expression, by targeting mRNAs and promoting either RNA degradation or translational repression. They are differentially regulated in the brain as well as other organs under hypoxic and ischemic conditions. Targeting microRNA expression/activity offers a potentially effective way to intervene against hypoxic and ischemic injury. In this review, we highlight recent updates with summary of our recent work, which provides an insight into the roles and mechanisms of microRNA-induced regulation of cellular and molecular processes in response to hypoxic and/or ischemic stress.
Keywords: Brain, heart, hypoxia, ischemia, kidney, microRNAs.
Current Medicinal Chemistry
Title:Effects of Hypoxia and Ischemia on MicroRNAs in the Brain
Volume: 22 Issue: 10
Author(s): Yilin Yang, Harleen K Sandhu, Feng Zhi, Fei Hua, Min Wu and Ying Xia
Affiliation:
Keywords: Brain, heart, hypoxia, ischemia, kidney, microRNAs.
Abstract: Hypoxia and ischemia play a major role in the pathogenesis of cerebrovascular diseases such as stroke. However, the protective strategies against hypoxic and ischemic insults are very limited in clinical settings. This has reinforced the need to improve our understanding of the hypoxic and ischemic cascades and explore novel solutions of hypoxic/ ischemic injury. Recent research has identified the crucial role of microRNAs in regulation of gene expression under hypoxic/ischemic conditions. These 19-24 ribonucleotide non-coding RNA molecules function as inhibitory modulators of gene expression, by targeting mRNAs and promoting either RNA degradation or translational repression. They are differentially regulated in the brain as well as other organs under hypoxic and ischemic conditions. Targeting microRNA expression/activity offers a potentially effective way to intervene against hypoxic and ischemic injury. In this review, we highlight recent updates with summary of our recent work, which provides an insight into the roles and mechanisms of microRNA-induced regulation of cellular and molecular processes in response to hypoxic and/or ischemic stress.
Export Options
About this article
Cite this article as:
Yang Yilin, Sandhu K Harleen, Zhi Feng, Hua Fei, Wu Min and Xia Ying, Effects of Hypoxia and Ischemia on MicroRNAs in the Brain, Current Medicinal Chemistry 2015; 22 (10) . https://dx.doi.org/10.2174/0929867322666150209154755
DOI https://dx.doi.org/10.2174/0929867322666150209154755 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Concepts on Cardiovascular Stent Devices
Mini-Reviews in Medicinal Chemistry Exploring the Cardio-metabolic Relevance of T-cadherin: A Pleiotropic Adiponectin Receptor
Endocrine, Metabolic & Immune Disorders - Drug Targets Prophylaxis of Erectile Function After Radical Prostatectomy with Phosphodiesterase Type 5 Inhibitors
Current Pharmaceutical Design Frailty Among Alzheimer’s Disease Patients
CNS & Neurological Disorders - Drug Targets Medicinal Chemistry of ATP Synthase: A Potential Drug Target of Dietary Polyphenols and Amphibian Antimicrobial Peptides
Current Medicinal Chemistry Recent Studies on Neural Tube Defects in Embryos of Diabetic Pregnancy: An Overview
Current Medicinal Chemistry Leptin and the Cardiovascular System: A Review
Recent Patents on Cardiovascular Drug Discovery The Role of Adipocytokines and Neurohormonal Dysregulation in Metabolic Syndrome
Current Diabetes Reviews Giant Pulmonary Artery Aneurysm Secondary To Patent Ductus Arteriosus: A Case Report
Current Cardiology Reviews Impact of Patient Knowledge of Hypertension Complications on Adherence to Antihypertensive Therapy
Current Hypertension Reviews Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types
Current Alzheimer Research Oxidized-LDL and Paraoxonase-1 As Biomarkers of Coronary Artery Disease in Patients with Sleep-Disordered Breathing
Current Medicinal Chemistry Myostatin Inhibition and Cardiometabolic Disorders
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Therapeutic Management Strategies for Type 2 Diabetes
Current Diabetes Reviews Complementary Role of Herbal Medicine and Exercise in Cardiovascular Disease Prevention and Management: A Review of Evidence
Current Pharmaceutical Design Nephron Number Reduction and Low Birth Weight: A Concern for the Paediatrician and Beyond
Current Pediatric Reviews Propionate: Hypophagic Effects Observed in Animal Models Might be Transposed to the Human Obesity Management
Current Nutrition & Food Science Metabolic Effects of a Diet with Inulin-Enriched Pasta in Healthy Young Volunteers
Current Pharmaceutical Design Editorial [Hot Topic: Drugs Targeting Atherosclerosis: Current and Emerging Approaches (Executive Editors: Vangelis G. Manolopoulos and Anna Tavridou)]
Current Pharmaceutical Design Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors
Clinical Cancer Drugs